Capital expenditure · 2015–2025
Regenxbio capital expenditure
$2.4M−0.9% · FY2025
Regenxbio (RGNX) reported $2.4M in capital expenditure for fiscal 2025, −0.9% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $2.4M | −0.9% | Open → |
| FY20242024-12-31 | $2.4M | −75.5% | Open → |
| FY20232023-12-31 | $10.0M | −67.6% | Open → |
| FY20222022-12-31 | $30.7M | −63.5% | Open → |
| FY20212021-12-31 | $84.2M | +213.3% | Open → |
| FY20202020-12-31 | $26.9M | +129.3% | Open → |
| FY20192019-12-31 | $11.7M | −11.7% | Open → |
| FY20182018-12-31 | $13.3M | +85.4% | Open → |
| FY20172017-12-31 | $7.2M | −12.1% | Open → |
| FY20162016-12-31 | $8.1M | +1,461.1% | Open → |
| FY20152015-12-31 | $522,000 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +16.5%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Regenxbio capital expenditure |url=https://companiesranked.com/en/company/regenxbio/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Regenxbio capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/regenxbio/capital-expenditureBibTeX
@misc{companiesranked-en-company-regenxbio-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Regenxbio capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/regenxbio/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001193125-26-094013 · March 5, 2026
{{cite web |title=Regenxbio capital expenditure — 10-K (0001193125-26-094013) |url=https://www.sec.gov/Archives/edgar/data/1590877/000119312526094013/rgnx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.